COVID-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials
PTI, Jul 3, 2020, 8:17 AM IST
New Delhi: After Bharat Biotech’s Covaxin, another potential COVID-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got nod from the Drugs Controller General of India (DCGI) on Thursday, July 2 for human clinical trials, government sources said.
The approval process was fast-tracked following a recommendation by the subject expert committee on COVID-19, considering the emergency and unmet medical need during the pandemic.
“DCGI Dr. V G Somani has given approval for the phase I and II clinical trials (on humans) of the potential novel coronavirus vaccine developed by Zydus Cadila Healthcare Ltd on Thursday after its animal studies were found to be successful,” an official source in the know of the developments told PTI.
“The assent for human trials was given after the company submitted data of clinical trial on animals to the DCGI, in which the vaccine candidate was found to be successful with respect to safety and immunogenicity,” sources said.
The company is likely to start enrolment of subjects soon.
“The phase I and II trials will take around three months to be completed,” the source said.
A couple of days earlier, the country’s ‘first’ indigenous COVID-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the Indican Council of Medical Research and National Institute of Virology (NIV), had got the nod for human clinical trials from the DCGI.
India’s COVID-19 tally rose to 6,04,641 on Thursday with a single-day increase of 19,148 cases, just five days after it crossed the five-lakh mark, while the death toll rose to 17,834 with 434 new fatalities, according to the Union Health Ministry.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
858 COVID-19 cases, 1 death in Karnataka
Mandaviya to chair crucial meeting with experts on rising COVID-19 cases
Karnataka reports 623 COVID-19 cases, 1 death
Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR study
Bengaluru: 31 children test COVID positive in Dasarahalli schools
MUST WATCH
Latest Additions
ED arrests director of Bengaluru-based real estate group on money laundering charges
Stay in forests for 15 days a month to boost morale of personnel: K’taka CM instructs officers
Political turmoil in Shiv Sena a battle between truth and lie; we will win: Aaditya Thackeray
Political motives behind textbook revision in Karnataka: Congress leader Ramanath Rai
Hardik relishes captaincy, says it brings best out of him